4//SEC Filing
Markus Richard 4
Accession 0001724521-25-000032
CIK 0001724521other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:10 PM ET
Size
6.9 KB
Accession
0001724521-25-000032
Insider Transaction Report
Form 4
Markus Richard
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-10+305,328→ 305,328 totalExercise: $12.45Exp: 2035-01-30→ Common Stock (305,328 underlying) - Award
Common Stock
2025-02-10+75,193→ 75,193 total
Footnotes (2)
- [F1]Represents the grant of restricted stock units that vest in four equal annual installments beginning March 15, 2026, subject to the Reporting Person's continued service to the Company.
- [F2]The option becomes exercisable in 48 equal monthly installments after February 1, 2025, subject to the Reporting Person's continued service to the Company
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0002056093
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 9:10 PM ET
- Size
- 6.9 KB